Dave A. Miller
Directeur Technique/Scientifique/R&D chez DisperSol Technologies LLC
Profil
Dave A.
Miller is currently the Chief Scientific Officer at DisperSol Technologies LLC.
Previously, he worked as a Senior Principal Scientist at Hoffmann-La Roche, Inc. He obtained his undergraduate and doctorate degrees from The University of Texas at Austin.
Postes actifs de Dave A. Miller
Sociétés | Poste | Début |
---|---|---|
DisperSol Technologies LLC
DisperSol Technologies LLC Pharmaceuticals: MajorHealth Technology DisperSol Technologies LLC offers plastics processing technology to pharmaceutical manufacturing companies. It offers KinetiSol, a pharmaceutical processing technology that provides solutions to oral drug delivery problems and for amorphous solid dispersion systems; and ArmoRx Platform, a processing technology that enables use of certain compendial pharmaceutical polymers to produce oral dosage forms that are inherently abuse deterrent. The company was founded by Gershon Yaniv in 2007 and is headquartered in Georgetown, TX. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Dave A. Miller
Sociétés | Poste | Fin |
---|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Formation de Dave A. Miller
The University of Texas at Austin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
DisperSol Technologies LLC
DisperSol Technologies LLC Pharmaceuticals: MajorHealth Technology DisperSol Technologies LLC offers plastics processing technology to pharmaceutical manufacturing companies. It offers KinetiSol, a pharmaceutical processing technology that provides solutions to oral drug delivery problems and for amorphous solid dispersion systems; and ArmoRx Platform, a processing technology that enables use of certain compendial pharmaceutical polymers to produce oral dosage forms that are inherently abuse deterrent. The company was founded by Gershon Yaniv in 2007 and is headquartered in Georgetown, TX. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |